• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

Hemoglobin-beta1 as cancer antigen against GIST

Research Project

  • PDF
Project/Area Number 22700898
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Tumor immunology
Research InstitutionJikei University School of Medicine

Principal Investigator

KOMITA Hideo  東京慈恵会医科大学, 医学部, 助教 (90534561)

Project Period (FY) 2010 – 2012
KeywordsGIST / Hemoglobin-beta1 / 周細胞 / Sutent
Research Abstract

Gastrointestinal stromal tumor (GIST) is the most common mesencymal tumor of the gastrointestinal tract. After surgical resection of primary tumor, tumor recurrence is frequent and 50% of patinets died within 5years of initial diagnosis. The KIT inhibitor imatinib mesylate is the reference treatment in the first line in advanced GISTs as adjuvant setting. However Imatinib mesylate is well tolerated in most patinets. Second line, Sunitinib malate is also similar situation.Recent results and reports suggest cancer vaccine treatment targeting the tumor-associated vasculature. CD8+T cells in regressor mice showed strong reactivity against HPLC eluted peptides (HBB1) by acid elution from surgical removed CMS4 lesions. In situimaging suggest GIST tumor vascular express HBB1 with pericyte markers(NG2, TEM1,RGS5,αSMA). TBVA vaccine against GIST should induce antipericyte Tc1 cells

  • Research Products

    (14 results)

All 2012 2011 2010

All Journal Article (9 results) Presentation (5 results)

  • [Journal Article] Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice.2012

    • Author(s)
      Zhao X, Bose A, Komita H, Taylor JL, Chi N, Lowe DB, Okada H, Cao Y, Mukhopahyay D, Cohen PA, Storkus WJ.
    • Journal Title

      J Immunol.

      Volume: 188(4) Pages: 1782-1788

    • DOI

      doi:10.4049/jimmunol. 1101644

  • [Journal Article] Immunotherapy synergizes with chemotherapy targeting pancreatic cancer.2012

    • Author(s)
      Koido S, Homma S, Takahara A, Namiki Y, Komita H, Uchiyama K, Ito M, Gong J, Ohkusa T, Tajiri H
    • Journal Title

      Immunotherapy.

      Volume: 4(1) Pages: 5-7

    • DOI

      Doi:10.2217/imt.11.150

  • [Journal Article] Current immunotherapeutic approaches in pancreatic cancer2011

    • Author(s)
      Koido S, Homma S, Takahara A, Namiki Y, Tsukinaga S, Mitobe J, Odahara S, Yukawa T, Matsudaira H, Nagatsuma K, Uchiyama K, Satoh K, Ito M, Komita H, Arakawa H, Ohkusa T, Gong J, Tajiri H
    • Journal Title

      Clin Dev immunol

      Volume: 2011 Pages: 267539

    • DOI

      Doi:10.1155/2011/267539

  • [Journal Article] Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune reponse2011

    • Author(s)
      Takahara A, Koido S, Ito M, Nagasaki E, Sagawa Y, Iwamoto T, Komita H, Ochi T, Fujiwara H, Yasukawa M, Mineno J, Shiku H, Nishida S, Sugiyama H, Tajiri H, Homma S.
    • Journal Title

      Cancer Immunol Immunother

      Volume: 60(9) Pages: 1289-1297

    • DOI

      Doi:10. 1007/s00262-011-1033-3

  • [Journal Article] Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.2011

    • Author(s)
      Koido S, Homma S, Takahara A, Namiki Y, Komita H, Nagasaki E, Ito M, Nagatsuma K, Uchiyama K, Satoh K, Ohkusa T, Gong J, Tajiri H.
    • Journal Title

      J Biomed Biotechnol

      Volume: 2011 Pages: 910836

    • DOI

      doi:10. 1155/2011/910836

  • [Journal Article] Intratumoral Il-12 gene therapy results in the crosspriming of Tc1 cells reactive against tumor associated stromal antigens.2011

    • Author(s)
      Zhao X, Bose A, Komita H, Taylor JL, Kawabe M, Chi N, Spokas L, Lowe DB, Goldbach C, Alber S, Watkins SC, Butterfield LH, Kalinski P, Kirkwood JM, Storkus WJ
    • Journal Title

      Mol Ther

      Volume: 19(4) Pages: 805-814

    • DOI

      doi:10. 1038/mt.2010.295

  • [Journal Article] [膵癌診療と研究の最先端] 進行膵癌に対するgemcitanbine併用WT1標的免疫療法の意義(解説/特集)2011

    • Author(s)
      小井戸薫雄、本間定、高原映崇、込田英夫、大草敏史、田尻久雄
    • Journal Title

      胆と膵

      Volume: 32(9) Pages: 887-891

  • [Journal Article] Regulation of tumor immunity by tumor/dendritic cell fusions.2010

    • Author(s)
      Koido S, Homma S, Hara E, Namiki Y, Takahara A, Komita H,Nagasaki E, Ito M, Ohkusa T, Gong J, Tajiri H
    • Volume
      201
    • Pages
      516768.
    • DOI

      doi:10.1155/2010/516768

  • [Journal Article] Dendritic/pancreatic carcinoma fusions for clinical use: Comparative functional analysis of healthy-versus patient-derived fusions2010

    • Author(s)
      Koido S, Hara E, Homma S, Namiki Y, Komita H,Takahara A, Nagasaki E, Ito M, Sagawa Y, Mitsunaga M, Uchiyama K, Satoh K, Arihiro S, Ohkusa T, Gong J, Tajiri H.
    • Journal Title

      Clin Immunol

      Volume: 135(3) Pages: 384-400

    • DOI

      doi:10.1016/j-clim.2010.02.003

  • [Presentation] 消化器癌の免疫学的解析と治療 腫瘍血管ペリサイトを標的とした新たながん免疫療法と GIST 治療への応用2012

    • Author(s)
      込田英夫、小井戸薫雄、本間定
    • Organizer
      日本消化器病学会雑誌109 巻臨時増総会pageA175
    • Year and Date
      20120300
  • [Presentation] 膵癌に対するゲムシタビン併用 WT1 ペプチドワクチン療法の臨床効果と免疫誘導(Memory WT1-CTLs is a useful marker to predict the clinical outcome: WT1 vaccine in the combination with gemcitabine)2011

    • Author(s)
      西田純幸、小井戸薫雄、原一馬、森本創世子、坪井昭博、本間定、武田裕、込田英夫、永野裕昭、岡芳弘、大草敏史、田尻久雄、杉山治夫
    • Organizer
      日本癌学会総会記事 70回page395
    • Year and Date
      20110900
  • [Presentation] iPS 細胞から腫瘍血管を標的とした癌ワクチンの開発(Generation of a cancer vaccine targeting tumor vessel from iPS cells)2011

    • Author(s)
      本間定、佐川由紀子、伊藤正紀、永崎栄次郎、高原映崇、込田英夫、小井戸薫雄
    • Organizer
      日本癌学会総会記事 70回 Page82
    • Year and Date
      20110900
  • [Presentation] iPS 細胞から腫瘍血管を標的とした癌ワクチン療法の作製2011

    • Author(s)
      本間定、佐川由紀子、伊藤正紀、永崎栄次郎、高原映崇、込田英夫、小井戸薫雄
    • Organizer
      日本がん免疫学会総会プログラム 15回 Page105
    • Year and Date
      20110600
  • [Presentation] 、WT1 ペプチドがん免疫療法の現状と将来膵がんに対する WT1 ペプチド免疫療法2010

    • Author(s)
      本間定、小井戸薫定、込田英夫、高原映崇、大草敏史、西田純幸、武田裕、岡芳弘、伊藤濤記、坪井昭博、杉山治夫
    • Organizer
      日本癌治療学会誌 45 巻 2 号 Page450
    • Year and Date
      20100900

URL: 

Published: 2014-08-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi